REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Beit Jala Pharamaceutical Co. (Palestine)

Main Activities: Medicinal and Botanical Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Beit Jala Pharamaceutical Co. Profile Updated: August 23, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

beit jala pharmaceutical company (BJP) is a pharmaceutical company. The company has 101-500 employees and claims to be committed to developing pure, safe, and effective pharmaceutical products.

Headquarters
81 Al-Madaress St-West Bank, P.O. Box 58
Bethlehem; West Bank; Postal Code: 97300

Contact Details: Purchase the Beit Jala Pharamaceutical Co. report to view the information.

Website: http://www.beitjalapharma.com

Basic Information
Total Employees:
Purchase the Beit Jala Pharamaceutical Co. report to view the information.
Outstanding Shares:
Purchase the Beit Jala Pharamaceutical Co. report to view the information.
Financial Auditors:
Purchase the Beit Jala Pharamaceutical Co. report to view the information.
Incorporation Date:
1955
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Vice Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Ownership Details
Purchase this report to view the information.
77.89%
Company Performance
Financial values in the chart are available after Beit Jala Pharamaceutical Co. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency JOD. Absolute financial data is included in the purchased report.
Net sales revenue
-8.76%▼
Total operating revenue
-8.83%▼
Operating profit (EBIT)
-19.08%▼
EBITDA
18.96%▲
Net Profit (Loss) for the Period
7.56%▲
Total assets
-1.89%▼
Total equity
7.21%▲
Operating Profit Margin (ROS)
-2.4%▼
Net Profit Margin
2.88%▲
Return on Equity (ROE)
0.01%▲
Debt to Equity Ratio
-1.52%▼
Quick Ratio
-0.27%▼
Cash Ratio
0.43%▲

Similar companies

Birzeit Pharmaceuticals Company Plc
 
Jerusalem Pharmaceuticals Co. Ltd
Dar Al-Shifa Pharmaceuticals Plc
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo